APPLICATION
ANDA078253
TYPE
ANDA
ORIGINAL APPROVAL
2007-09-11
LATEST ACTION
2024-05-31
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
ALLOPURINOLDiscontinued
ALLOPURINOL 300MG · TABLET · ORAL
ALLOPURINOLDiscontinued
ALLOPURINOL 100MG · TABLET · ORAL
Approval history
2024-05-31Labeling · Supplement 13 · standardAP
2019-04-23Labeling · Supplement 12 · standardAP
2015-05-01Labeling · Supplement 5 · standardAP
2015-05-01Labeling · Supplement 6 · standardAP
2011-12-31Labeling · Supplement 4AP
2007-09-11OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.